.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Healthtrust
Covington
McKesson
Chinese Patent Office
Daiichi Sankyo
Chubb
Fuji
Farmers Insurance
Medtronic

Generated: December 16, 2017

DrugPatentWatch Database Preview

THALITONE Drug Profile

« Back to Dashboard

Which patents cover Thalitone, and when can generic versions of Thalitone launch?

Thalitone is a drug marketed by Casper Pharma Llc and Monarch Pharms and is included in two NDAs.

The generic ingredient in THALITONE is chlorthalidone. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
Drug patent expirations by year for THALITONE

Pharmacology for THALITONE

Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis

Medical Subject Heading (MeSH) Categories for THALITONE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma LlcTHALITONEchlorthalidoneTABLET;ORAL019574-001Dec 20, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Casper Pharma LlcTHALITONEchlorthalidoneTABLET;ORAL019574-002Feb 12, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Monarch PharmsTHALITONEchlorthalidoneTABLET;ORAL088051-001Nov 12, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Novartis
QuintilesIMS
Federal Trade Commission
McKinsey
Harvard Business School
Cantor Fitzgerald
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot